Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W F Pickl

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Journal of Inherited Metabolic Disease|July 10, 2009
Danon disease: case report and detection of new mutationG Regelsberger, R Höftberger, W F Pickl, et al.
European Journal of Clinical Investigation|March 27, 2009
Targeting of mTOR is associated with decreased growth and decreased VEGF expression in acute myeloid leukaemia cellsA Böhm, K J Aichberger, M Mayerhofer, et al.
Allergy|September 30, 2017
Distinct epitope structures of defensin-like proteins linked to proline-rich regions give rise to differences in their allergenic activityI Pablos, S Eichhorn, Y Machado, et al.
Current Cancer Drug Targets|June 11, 2009
Targeting of Hsp32 in solid tumors and leukemias: a novel approach to optimize anticancer therapyK V Gleixner, M Mayerhofer, A Vales, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Journal of Inherited Metabolic Disease|July 10, 2009
Danon disease: case report and detection of new mutationG Regelsberger, R Höftberger, W F Pickl, et al.
European Journal of Clinical Investigation|March 27, 2009
Targeting of mTOR is associated with decreased growth and decreased VEGF expression in acute myeloid leukaemia cellsA Böhm, K J Aichberger, M Mayerhofer, et al.
Allergy|September 30, 2017
Distinct epitope structures of defensin-like proteins linked to proline-rich regions give rise to differences in their allergenic activityI Pablos, S Eichhorn, Y Machado, et al.
Current Cancer Drug Targets|June 11, 2009
Targeting of Hsp32 in solid tumors and leukemias: a novel approach to optimize anticancer therapyK V Gleixner, M Mayerhofer, A Vales, et al.
Pageof 5